Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Jul 26, 2021
Date Accepted: Feb 8, 2022
Date Submitted to PubMed: Feb 9, 2022

The final, peer-reviewed published version of this preprint can be found here:

The Impact of Telemedicine Visits on the Controlling High Blood Pressure Quality Measure During the COVID-19 Pandemic: Retrospective Cohort Study

Ye S, Anstey DE, Grauer A, Metser G, Moise N, Schwartz J, Kronish I, Abdalla M

The Impact of Telemedicine Visits on the Controlling High Blood Pressure Quality Measure During the COVID-19 Pandemic: Retrospective Cohort Study

JMIR Form Res 2022;6(3):e32403

DOI: 10.2196/32403

PMID: 35138254

PMCID: 8945081

The Impact of Telemedicine Visits on Controlling High Blood Pressure Quality Measure During the Covid-19 Pandemic: Observational Study

  • Siqin Ye; 
  • D. Edmund Anstey; 
  • Anne Grauer; 
  • Gil Metser; 
  • Nathalie Moise; 
  • Joseph Schwartz; 
  • Ian Kronish; 
  • Marwah Abdalla

ABSTRACT

Background:

Telemedicine use vastly expanded during the Covid-19 pandemic, with uncertain impact on cardiovascular care quality.

Objective:

We sought to examine the association between telemedicine use and blood pressure (BP) control.

Methods:

This is a retrospective cohort study of 32,727 adult patients with hypertension (HTN) seen in primary care and cardiology clinics at an urban, academic medical center from February to December, 2020. The primary outcome was poor BP control, defined as having no BP recorded OR if the last recorded BP was ≥140/90 mmHg. Multivariable logistic regression was used to assess the association between telemedicine use during the study period (none, 1 telemedicine visit, 2+ telemedicine visits) and poor BP control, adjusting for demographic and clinical characteristics.

Results:

During the study period, no BP was recorded for 486/20,745 (2.3%) patients with in-person visits only, for 1,863/6,878 (27.1%) patients with 1 telemedicine visit, and for 1,277/5,104 (25.0%) patients with 2+ telemedicine visits. After adjustment, telemedicine use was associated with poor BP control (odds ratio [OR], 2.06, 95% confidence interval [CI] 1.94 to 2.18, p<.001 for 1 telemedicine visit, and OR 2.49, 95% CI 2.31 to 2.68, p<.001 for 2+ telemedicine visits; reference, in-person visit only). This effect disappears when analysis was restricted to patients with at least one recorded BP (OR 0.89, 95% CI 0.83 to 0.95, p=.001 for 1 telemedicine visit, and OR 0.91, 95% CI 0.83 to 0.99, p=.03 for 2+ telemedicine visits).

Conclusions:

BP is less likely to be recorded during telemedicine visits, but telemedicine use does not negatively impact BP control when BP is recorded. Clinical Trial: NA


 Citation

Please cite as:

Ye S, Anstey DE, Grauer A, Metser G, Moise N, Schwartz J, Kronish I, Abdalla M

The Impact of Telemedicine Visits on the Controlling High Blood Pressure Quality Measure During the COVID-19 Pandemic: Retrospective Cohort Study

JMIR Form Res 2022;6(3):e32403

DOI: 10.2196/32403

PMID: 35138254

PMCID: 8945081

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.